Immune Cell Dysregulation as a Mediator of Fibrosis in Systemic Sclerosis

Investigators summarize the most pertinent findings concerning the involvement of dysregulated immune responses in fibrosis of the skin and lungs in systemic sclerosis (SSc) and highlight the current and potential immune-based targets for SSc therapeutics.